MOUNJARO
Active substance: tirzepatide
INJECTION, SOLUTION · TIRZEPATIDE 10 mg/.5mL
United StatesActive
Marketing holder: A-S Medication Solutions
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 3
- TIRZEPATIDE · 10 mg/.5mL
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| RU 7 |
|
| EU 1 |
|
Control by country
- Russiaprescription only
Source: GRLS (Russian state register) · record 01a120c3-9832-7ede-a626-5a8aa1d8a807,01a120c3-a961-79d0-8577-921f81013541,01a120c3-d9c2-7667-b5e6-f477d0137d94,01a120c3-e4af-7a56-b8ab-945537d049c1,01a120c3-fc3d-758f-902c-ca2159af1eba;count=6 · valid from 2026-10-09 · verified 2026-10-09
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-2b56-7b57-8f51-ce0507d4ad09,01a1208c-4de3-7025-9fde-c49aac756ab0,01a1208c-6180-7289-88f3-00f60014ada3,01a1208c-6a5d-712f-bda2-6a0599d9ccda,01a1208c-8443-792a-90c5-fb1d06a8041e;count=54 · valid from 2026-10-09 · verified 2026-10-09
- Registration number
- 50090-8021
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- SUBCUTANEOUS
- product · openFDA NDC · 50090-8021 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 50090-8021 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 50090-8021 · Verified 2026-10-09 · open in source